Gene delivery to neuroblastoma cells by polyethylenimine- liposome copolymers
Publish place: 3rd INTERNATIONAL NASTARAN CANCER SYMPOSIUM
Publish Year: 1396
نوع سند: مقاله کنفرانسی
زبان: English
View: 621
نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
NASTARANCANSER03_192
تاریخ نمایه سازی: 7 اسفند 1396
Abstract:
Gene therapy is one of the potential alternatives in the cancer treatment, It s advantaged contain high selectivity and limited side effects, but lack of efficient and safe nucleic acids delivery system is the most limiting problem. The cationic polymers and lipid-based nonviral vectors have mainly introduced for gene delivery purposes. In the present study, we utilized benefits of both cationic liposomes andcationic polymer vectors. we bound dexamethasone (Dexa) to branched polyethyleneimine (b-PEI), in combinations with cationic liposomes as a nonviral system to improve transfection efficiency. Lipopolyplex was developed by premixing liposome (DOTAP and cholesterol) and different Mw of bPEI-Dexa as carriers following by addition of plasmid at three different C/P ratios. Transfectionefficiency of these vectors in neuro2A,a mouse neuroblastoma cell line was determined by Luciferase reporter gene assay.Lipopolyplexes were more efficient than polyplexes and lipoplexes alone andtransfection efficiency was improved by adding dexamethasone. The complexes containing liposome, PEI 10 kDa and dexamethasone (PEI10: Lipo:Dexa(0.05)) had the highest transfection activity about40 fold and 3.6 fold in compare with PEI10 and PEI10:Lipo, respectively.The results of this study confirmed that obtained lipopolyplex deliver gene to cancer cell efficiency. Moreover, using dexamethasone, in combination with lipopolyplex might be useful to increase the gene delivery potential of these lipopolyplexes
Keywords:
Gene and Cancer , Cell and Cancer , Cancer Genetics , Cancer Treatment and Management , Drugs and Cancer
Authors
Saeedeh Askarian
Research Center Of Advanced Technologies In Medicine, Torbat Heydariyeh University Of Medical Sciences, Torbat Heydariyeh, Iran
Reza Kazemi Oskuee
Targeted Drug Delivery Research Center, Mashhad University Of Medical Sciences, Mashhad,Iran
Bizhan Malaekeh-Nikouei
Nanotechnology Research Center, School Of Pharmacy, Mashhad University Of Medical Sciences, Mashhad, Iran
Fariba Asghari
School Of Pharmacy, Mashhad University Of Medical Sciences, Mashhad, Iran